Shigellemia.

An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog (2015) 0.81

Comparative virulence of blood and stool isolates of Shigella sonnei. J Clin Microbiol (1994) 0.76

Shigella bacteremia in a patient with visceral leishmaniasis. Case Rep Crit Care (2013) 0.75

Blood cultures: principles and techniques. Mayo Clin Proc (1975) 4.87

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95

The gay bowel syndrome: clinico-pathologic correlation in 260 cases. Ann Clin Lab Sci (1976) 1.98

Serum factors responsible for killing of Shigella. Immunology (1974) 1.56

Shigella sonnei bacteremia. Unusual antibody response from immunosuppressive therapy following renal transplantation. Urology (1974) 1.53

Extraintestinal manifestations of shigellosis. Am J Gastroenterol (1970) 1.25

Bacillaemia due to Shigella sonnei. Lancet (1951) 1.19

Meningitis and septicemia due to shigellae in a newborn infant. J Pediatr (1967) 1.16

Septicemia and enterocolitis due to Shigella sonnei in a newborn infant. Pediatrics (1968) 1.12

Shigella infection in African and Indian children with special reference to Shigella septicemia. J Pediatr (1978) 1.00

Shigella sonnei bacteremia. Case report and review of the literature. JAMA (1962) 0.99

Shigella infections. Clin Gastroenterol (1979) 0.98

Rifampicin therapy in Gram-negative bacteraemia in infancy. Arch Dis Child (1973) 0.96

Septicaemic manifestations of shigellosis. Indian J Med Res (1979) 0.92

[SEPTICEMIA CAUSED BY SHIGELLA. APROPOS OF 2 NEW CASES]. Med Trop (Mars) (1965) 0.86

Shigella sonnei septicaemia in a neonate. Br Med J (1974) 0.84

COLIFORM SEPTICEMIA COMPLICATING SHIGELLOSIS IN CHILDREN. JAMA (1965) 0.84

Shigella boydii bacteremia. J Pediatr (1969) 0.82

Shiga bacillus dysentery complicated by bacteremia and disseminated intravascular coagulation. J Pediatr (1973) 0.82

Letter: Shigella sonnei septicaemia in a child with acute monocytic leukaemia. Br Med J (1974) 0.80

Bacillary dysentery with bacteremia. Am J Med Technol (1956) 0.79

Bacteremia caused by Shigella flexneri. Tex Med (1979) 0.79

Shigella and shigellaemia. Scand J Infect Dis (1981) 0.79

Fatal Shigella sonnei septicaemia in an adult complicated by marrow aplasia and intestinal perforation. J Infect (1981) 0.78

Skin lesions and shigellosis. Am J Trop Med Hyg (1969) 0.78

Shigella bacteremia in a patient with sickle cell anemia. Am J Dis Child (1972) 0.78

Letter: Leukaemoid reaction, haemolytic anaemia, and hyponatraemia in severe Shigella dysenteriae type-1 infection. Lancet (1974) 0.78

Extraintestinal shigellosis: bacteremia and paroxysmal atrial tachycardia. Shigella sonnei in a three-year-old boy. Clin Pediatr (Phila) (1973) 0.77

Purulent meningitis caused by Shigella flexneri. A case report. J S C Med Assoc (1971) 0.77

Shigella sonnei osteomyelitis and sickle-cell anemia. Am J Dis Child (1968) 0.77

Shigellosis: complications and associated diseases in infants and children. J Ky Med Assoc (1968) 0.77

Shigella septicemia in the newborn infant. J Pediatr (1967) 0.77

Shigella bacteraemia in Africans. Trans R Soc Trop Med Hyg (1978) 0.77

[Three cases of septicemia caused by dysentery bacilli observed at Dakar (three positive blood cultures of Sh. dysenteriae I, Sh. flexneri 5 Vi+ and Sh. sonnei)]. Ann Inst Pasteur (Paris) (1957) 0.77

Shigella flexneri bacteraemia: report of a case. West Afr Med J (1966) 0.77

The isolation of Shigella flexneri from blood cultures in acute shigellosis. J S C Med Assoc (1963) 0.77

[Sepsis caused by Shigella. A new registered case]. Rev Clin Esp (1980) 0.77

Outbreak of shigellosis resembling enterovirus. South Med J (1963) 0.77

Shigellemia without shigella diarrhea. Report of a case. Am J Clin Pathol (1966) 0.76

Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol (1971) 10.60

Obfuscation of the activity of antifungal antimicrobics by culture media. J Infect Dis (1972) 7.47

Nuclease production and lysostaphin susceptibility of Staphylococcus aureus and other catalase-positive cocci. Appl Microbiol (1971) 3.40

Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med (1972) 2.43

Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester. J Infect Dis (1976) 2.31

Diagnostic usefulness and safety of transtracheal aspiration. N Engl J Med (1967) 2.23

Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents. Antimicrob Agents Chemother (1977) 2.09

Problems in the diagnosis and treatment of systemic candidiasis. J Infect Dis (1972) 1.83

Miconazole therapy for coccidioidomycosis. JAMA (1974) 1.81

Penetration of antimicrobial agents into bronchial secretions. Am J Med (1975) 1.74

Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol (1990) 1.57

Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis (1971) 1.55

Comparison of amphotericin B and amphotericin B methyl ester: efficacy in murine coccidioidomycosis and toxicity. J Infect Dis (1976) 1.52

Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole. J Infect Dis (1975) 1.50

Effect of buffers on testing of Candida species susceptibility to flucytosine. J Clin Microbiol (1987) 1.44

Chemotherapy of systemic fungal diseases. Annu Rev Pharmacol Toxicol (1978) 1.39

Development of resistance to 5-fluorocytosine in Candida parapsilosis during therapy. J Infect Dis (1974) 1.38

Experimental and clinical aspects of resistance determinants. Mode of resistance against beta-lactam antibiotics in staphylococci. Ann N Y Acad Sci (1971) 1.36

Gentamicin versus staphylococcus aureus. J Infect Dis (1969) 1.36

Disk agar diffusion susceptibility testing of yeasts. Antimicrob Agents Chemother (1978) 1.35

Thermonuclease seroinhibition test for distinguishing Staphylococcus aureus from other coagulase-positive staphylococci. J Clin Microbiol (1979) 1.32

Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31

Influence of culture medium on susceptibility testing with BAY n 7133 and ketoconazole. J Clin Microbiol (1986) 1.30

An unusual outbreak of windborne coccidioidomycosis. N Engl J Med (1979) 1.27

Bacteriology of the lower respiratory tract as determined by fiber-optic bronchoscopy and transtracheal aspiration. J Infect Dis (1976) 1.23

Metachromatic agar-diffusion microslide technique for detecting staphylococcal nuclease in foods. Appl Microbiol (1972) 1.20

Nocardial brain abscess cured with cycloserine and sulfonamides. Am J Med Sci (1968) 1.20

Occurrence of protein A in Staphylococcus aureus and closely related Staphylococcus species. J Clin Microbiol (1979) 1.18

Effect of tetracycline, polymyxin B, and rifampin on phagocytosis. Clin Pharmacol Ther (1970) 1.17

Stability of four antifungal antimicrobics in vitro. J Infect Dis (1978) 1.17

Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother (1980) 1.16

Comparative pharmacology of amphotericin B and amphotericin B methyl ester in the non-human primate, Macacca mulatta. Antimicrob Agents Chemother (1977) 1.15

Treatment of open fractures: a prospective study. J Trauma (1983) 1.10

Convenient assay for staphylococcal nuclease by the metachromatic well-agar-diffusion technique. Appl Microbiol (1972) 1.10

Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. Ann Intern Med (1977) 1.08

Susceptibility of "methicillin"-resistant Staphylococcus aureus to 12 antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1969) 1.05

Effect of nitrogen dioxide on pulmonary bacterial defense mechanisms. Arch Environ Health (1973) 1.05

Infective endocarditis caused by Streptococcus bovis resistant to the lethal effect of penicillin G. Arch Intern Med (1978) 1.03

Tolerance of staphylococcal thermonuclease to stress. Appl Microbiol (1972) 1.03

The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02

Acquired and native resistance of Staphylococcus aureus to cephalexin and other beta-lactam antibiotics. Appl Microbiol (1970) 1.01

Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin. J Infect Dis (1976) 1.00

Comparative acute toxicity of four drugs. A study of neomycin, gentamicin, kanamycin, and dihydrostreptomycin. Arch Intern Med (1967) 0.99

Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation. Biochemistry (1983) 0.98

Successful treatment of gram-negative bacillary meningitis with moxalactam. Ann Intern Med (1981) 0.98

The polymyxins. Med Clin North Am (1970) 0.97

Grouping of gram-negative bacteria and susceptibility to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 0.94

In vitro activities of two new antifungal azoles. Antimicrob Agents Chemother (1984) 0.94

Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med (1982) 0.94

Adverse influence of ozone on pulmonary bactericidal activity of murine lung. Nature (1971) 0.94

Susceptibility of staphylococci to new antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1967) 0.93

Evidence for a role of the amino-terminal region in the biological activity of the classical anaphylatoxin, porcine C5a des-Arg-74. J Biol Chem (1985) 0.91

Comparative susceptibility of four kinds of pathogenic fungi to amphotericin B and amphotericin B methyl ester. Antimicrob Agents Chemother (1978) 0.91

Providence bacillus bacteremia and septicopyemia. Am J Med (1968) 0.91

Purification of High Titer Tetanus Toxin. J Bacteriol (1945) 0.90

Reproducible method for induction of pulmonary coccidioidomycosis in mice. J Infect Dis (1977) 0.90

Ozone and the antibacterial defense mechanisms of the murine lung. Arch Intern Med (1971) 0.88

In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother (1979) 0.88

Parenteral sodium ampicillin therapy of endocarditis, salmonellosis, and other bacterial infections. Antimicrob Agents Chemother (Bethesda) (1965) 0.88

Recovery from encephalomyelitis caused by Herpesvirus simiae. Report of a case. Arch Intern Med (1975) 0.88

Acquisition of coccidioidomycosis at necropsy by inhalation of coccidioidal endospores. Diagn Microbiol Infect Dis (1992) 0.88

Entry of four cephalosporins into the ovine lung. J Infect Dis (1984) 0.87

Reliability of a commercial triphenyltetrazolium chloride reduction test for detecting significant bacteriuria. Am J Med Sci (1966) 0.87

Etiologic diagnosis of lower respiratory tract infections. Calif Med (1970) 0.86

Cold sterilization of ureteral catheters with ethylene oxide gas. J Urol (1966) 0.86

Antibodies that neutralize human beta interferon biologic activity recognize a linear epitope: analysis by synthetic peptide mapping. Proc Natl Acad Sci U S A (1991) 0.85

Entry of four tetracyclines into saliva and tears. Antimicrob Agents Chemother (1974) 0.85

Toxicity of amphotericins on chronic administration to mongrel dogs. Diagn Microbiol Infect Dis (1985) 0.84

In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Antimicrob Agents Chemother (1973) 0.84

The penicillins, old and new. Review and perspectives. Calif Med (1968) 0.83

New antifungal drugs in the therapy of systemic mycoses. Scand J Infect Dis Suppl (1978) 0.82

Analysis of bacterial isolates from cerebrospinal fluid. J Clin Microbiol (1984) 0.81

Engulfment and bactericidal capabilities of peripheral blood leukocytes in chronic leukemias. Cancer (1969) 0.81

A synthetic nonapeptide corresponding to the NH2-terminal sequence of C3d-K causes leukocytosis in rabbits. J Biol Chem (1985) 0.81

The effects of anesthetic agents on murine pulmonary bactericidal activity. Anesthesiology (1971) 0.80

Influence of culture media on the antistaphylococcal activity of fosfomycin. Appl Microbiol (1971) 0.80

Quantitative microbiology of traumatic orthopedic wounds. J Clin Microbiol (1978) 0.80

Cellular receptors to the anaphylatoxins C3a and C5a. Biochem Soc Symp (1986) 0.79

Typhoid fever caused by chloramphenicol-resistant organisms. JAMA (1973) 0.79

Diagnostic value of gallium and bone scans in evaluation of extrapulmonary coccidioidal lesions. Am Rev Respir Dis (1980) 0.79

Antifungal chemotherapy. Prog Drug Res (1995) 0.78

Effect of cycloserines on D-amino acid oxidase. Arch Biochem Biophys (1966) 0.77

Influence of anesthetic agents on murine pulmonary bactericidal activity. Antimicrob Agents Chemother (Bethesda) (1970) 0.77

New antimicrobics for the treatment of infections caused by gram-negative bacilli. Med Clin North Am (1967) 0.77

Bioactive complement fragments in immunoregulation. Immunol Lett (1985) 0.76

The changing face of pneumonia. Hosp Pract (1979) 0.76

Activity of BAY n 7133 and BAY 1 9139 in vitro and in experimental murine coccidioidomycosis. Eur J Clin Microbiol (1985) 0.76

Entry of five antifungal agents into the ovine lung. Antimicrob Agents Chemother (1987) 0.76

Effect of vitamin E and ozone on the pulmonary antibacterial defense mechanisms. J Lab Clin Med (1974) 0.76

Tracheobronchial flora in chronic obstructive pulmonary disease: preliminary results with authentic specimens and trial of trimethoprim-sulfamethoxazole. J Infect Dis (1973) 0.76

Treatment of coccidioidomycosis with miconazole. JAMA (1980) 0.76

Helical conformation at the carboxy-terminal portion of human C3a is required for full activity. Biochemistry (1986) 0.76

Trimethoprim-sulfamethoxazole in chronic bronchitis. Can Med Assoc J (1975) 0.75

Long-term venous access in rhesus monkeys. Antimicrob Agents Chemother (1982) 0.75

Illicit intravenous drug use and bacterial endocarditis. Calif Med (1973) 0.75

Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature. Tex Heart Inst J (1986) 0.75

Lymphangiography in diagnosis of fever of unknown origin. Calif Med (1973) 0.75

Totally synthetic medium for susceptibility testing. Antimicrob Agents Chemother (1978) 0.75

Chemotherapy for systemic mycoses. Prog Drug Res (1989) 0.75

Elimination half-life of amphotericin B. J Infect (1990) 0.75